May Potentially Increase Mobility in People with Peripheral Artery Disease Peripheral artery disease is a blockage of vessels in the peripheral areas of the body (most commonly legs) and its usually caused by the buildup of fatty plaque in the arteries, or atherosclerosis
These medicinesincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)work by mimicking the action of the naturally occurring GLP-1 hormone
GLP-1 receptor agonists have entered the cultural bloodstream as forcefully as any medication in recent memory with more than one in eight Americans now reporting having used one, and TikTok hosting over 384,500 posts tagged #Ozempic as of early 2025
Sample sizes are n = 4/3/4/4/4 mice (j) and n = 3/3/3/3 mice (k-m)
Bibcode:1995FEBSL.358..219W
For insured patients, copays and coinsurance determine out-of-pocket costs, so immediate price hikes are unlikely